US Stock MarketDetailed Quotes

Immunome (IMNM)

Watchlist
  • 23.170
  • +0.060+0.26%
Trading May 6 11:03 ET
2.62BMarket Cap-9.53P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Immunome (IMNM) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
-23.23%6.94M
0
0
69.84%4.02M
184.35%2.93M
-35.50%9.04M
-28.44%2.74M
-18.37%2.91M
-44.55%2.36M
-56.47%1.03M
Operating revenue
-23.23%6.94M
--0
--0
69.84%4.02M
184.35%2.93M
-35.50%9.04M
-28.44%2.74M
-18.37%2.91M
-44.55%2.36M
-56.47%1.03M
Cost of revenue
Gross profit
Operating expense
-26.61%231.05M
-14.99%72.86M
12.55%60.14M
19.16%50.49M
-64.33%47.56M
154.83%314.84M
-12.97%85.71M
551.77%53.43M
322.21%42.37M
1,850.67%133.33M
Selling and administrative expenses
32.81%43.77M
15.75%12.09M
14.90%10.95M
43.91%10.04M
78.02%10.69M
67.65%32.96M
29.93%10.45M
117.74%9.53M
61.53%6.98M
105.51%6.01M
-General and administrative expense
32.81%43.77M
15.75%12.09M
14.90%10.95M
43.91%10.04M
78.02%10.69M
67.65%32.96M
29.93%10.45M
117.74%9.53M
61.53%6.98M
105.51%6.01M
Research and development costs
-33.56%187.29M
-19.26%60.77M
12.04%49.19M
14.28%40.45M
-71.04%36.87M
171.33%281.89M
-16.78%75.26M
1,048.47%43.91M
519.23%35.4M
3,153.85%127.32M
Operating profit
26.71%-224.11M
12.18%-72.86M
-19.03%-60.14M
-16.17%-46.48M
66.26%-44.64M
-179.19%-305.8M
12.34%-82.97M
-990.48%-50.52M
-593.04%-40.01M
-2,859.05%-132.3M
Net non-operating interest income expense
-8.71%11.72M
8.82%2.96M
-21.65%2.68M
-20.74%3.08M
6.73%3M
371.26%12.84M
34.77%2.72M
1,088.19%3.42M
1,699.54%3.89M
1,296.52%2.81M
Non-operating interest income
-8.71%11.72M
8.82%2.96M
-21.65%2.68M
-20.74%3.08M
6.73%3M
371.26%12.84M
34.77%2.72M
1,088.19%3.42M
1,699.54%3.89M
1,296.52%2.81M
Other net income (expense)
-88.54%-152.34M
-27.37M
-6.71M
-6.31M
-111.95M
Special income (charges)
----
----
----
--0
--0
-88.54%-152.34M
66.12%-27.37M
---6.71M
---6.31M
---111.95M
-Less：Restructuring and merger&acquisition
----
----
----
----
----
88.54%152.34M
-66.12%27.37M
--6.71M
--6.31M
--111.95M
-Less:Other special charges
----
----
----
----
----
88.54%152.34M
--27.37M
--6.71M
--6.31M
--111.95M
Income before tax
27.50%-212.39M
12.90%-69.9M
-21.99%-57.46M
-20.14%-43.4M
67.84%-41.64M
-174.29%-292.96M
13.37%-80.25M
-984.00%-47.1M
-550.03%-36.12M
-2,932.60%-129.49M
Income tax
Net income
27.50%-212.39M
12.90%-69.9M
-21.99%-57.46M
-20.14%-43.4M
67.84%-41.64M
-174.29%-292.96M
13.37%-80.25M
-984.00%-47.1M
-550.03%-36.12M
-2,932.60%-129.49M
Net income continuous Operations
27.50%-212.39M
12.90%-69.9M
-21.99%-57.46M
-20.14%-43.4M
67.84%-41.64M
-174.29%-292.96M
13.37%-80.25M
-984.00%-47.1M
-550.03%-36.12M
-2,932.60%-129.49M
Minority interest income
Net income attributable to the parent company
27.50%-212.39M
12.90%-69.9M
-21.99%-57.46M
-20.14%-43.4M
67.84%-41.64M
-174.29%-292.96M
13.37%-80.25M
-984.00%-47.1M
-550.03%-36.12M
-2,932.60%-129.49M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
27.50%-212.39M
12.90%-69.9M
-21.99%-57.46M
-20.14%-43.4M
67.84%-41.64M
-174.29%-292.96M
13.37%-80.25M
-984.00%-47.1M
-550.03%-36.12M
-2,932.60%-129.49M
Basic earnings per share
51.40%-2.43
41.41%-0.75
16.67%-0.65
16.67%-0.5
79.28%-0.52
7.06%-5
40.24%-1.28
-116.67%-0.78
-30.43%-0.6
-617.14%-2.51
Diluted earnings per share
51.40%-2.43
41.41%-0.75
16.67%-0.65
16.67%-0.5
79.28%-0.52
7.06%-5
40.24%-1.28
-116.67%-0.78
-30.43%-0.6
-617.14%-2.51
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue -23.23%6.94M0069.84%4.02M184.35%2.93M-35.50%9.04M-28.44%2.74M-18.37%2.91M-44.55%2.36M-56.47%1.03M
Operating revenue -23.23%6.94M--0--069.84%4.02M184.35%2.93M-35.50%9.04M-28.44%2.74M-18.37%2.91M-44.55%2.36M-56.47%1.03M
Cost of revenue
Gross profit
Operating expense -26.61%231.05M-14.99%72.86M12.55%60.14M19.16%50.49M-64.33%47.56M154.83%314.84M-12.97%85.71M551.77%53.43M322.21%42.37M1,850.67%133.33M
Selling and administrative expenses 32.81%43.77M15.75%12.09M14.90%10.95M43.91%10.04M78.02%10.69M67.65%32.96M29.93%10.45M117.74%9.53M61.53%6.98M105.51%6.01M
-General and administrative expense 32.81%43.77M15.75%12.09M14.90%10.95M43.91%10.04M78.02%10.69M67.65%32.96M29.93%10.45M117.74%9.53M61.53%6.98M105.51%6.01M
Research and development costs -33.56%187.29M-19.26%60.77M12.04%49.19M14.28%40.45M-71.04%36.87M171.33%281.89M-16.78%75.26M1,048.47%43.91M519.23%35.4M3,153.85%127.32M
Operating profit 26.71%-224.11M12.18%-72.86M-19.03%-60.14M-16.17%-46.48M66.26%-44.64M-179.19%-305.8M12.34%-82.97M-990.48%-50.52M-593.04%-40.01M-2,859.05%-132.3M
Net non-operating interest income expense -8.71%11.72M8.82%2.96M-21.65%2.68M-20.74%3.08M6.73%3M371.26%12.84M34.77%2.72M1,088.19%3.42M1,699.54%3.89M1,296.52%2.81M
Non-operating interest income -8.71%11.72M8.82%2.96M-21.65%2.68M-20.74%3.08M6.73%3M371.26%12.84M34.77%2.72M1,088.19%3.42M1,699.54%3.89M1,296.52%2.81M
Other net income (expense) -88.54%-152.34M-27.37M-6.71M-6.31M-111.95M
Special income (charges) --------------0--0-88.54%-152.34M66.12%-27.37M---6.71M---6.31M---111.95M
-Less：Restructuring and merger&acquisition --------------------88.54%152.34M-66.12%27.37M--6.71M--6.31M--111.95M
-Less:Other special charges --------------------88.54%152.34M--27.37M--6.71M--6.31M--111.95M
Income before tax 27.50%-212.39M12.90%-69.9M-21.99%-57.46M-20.14%-43.4M67.84%-41.64M-174.29%-292.96M13.37%-80.25M-984.00%-47.1M-550.03%-36.12M-2,932.60%-129.49M
Income tax
Net income 27.50%-212.39M12.90%-69.9M-21.99%-57.46M-20.14%-43.4M67.84%-41.64M-174.29%-292.96M13.37%-80.25M-984.00%-47.1M-550.03%-36.12M-2,932.60%-129.49M
Net income continuous Operations 27.50%-212.39M12.90%-69.9M-21.99%-57.46M-20.14%-43.4M67.84%-41.64M-174.29%-292.96M13.37%-80.25M-984.00%-47.1M-550.03%-36.12M-2,932.60%-129.49M
Minority interest income
Net income attributable to the parent company 27.50%-212.39M12.90%-69.9M-21.99%-57.46M-20.14%-43.4M67.84%-41.64M-174.29%-292.96M13.37%-80.25M-984.00%-47.1M-550.03%-36.12M-2,932.60%-129.49M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 27.50%-212.39M12.90%-69.9M-21.99%-57.46M-20.14%-43.4M67.84%-41.64M-174.29%-292.96M13.37%-80.25M-984.00%-47.1M-550.03%-36.12M-2,932.60%-129.49M
Basic earnings per share 51.40%-2.4341.41%-0.7516.67%-0.6516.67%-0.579.28%-0.527.06%-540.24%-1.28-116.67%-0.78-30.43%-0.6-617.14%-2.51
Diluted earnings per share 51.40%-2.4341.41%-0.7516.67%-0.6516.67%-0.579.28%-0.527.06%-540.24%-1.28-116.67%-0.78-30.43%-0.6-617.14%-2.51
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +16.82%
Sample Name
Sample Code
 +11.66%
Sample Name
Sample Code
 +9.49%
4
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+8.30%
5
United States Oil Fund LP
USO
+7.22%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +29.12%
Sample Name
Sample Code
 +16.86%
Sample Name
Sample Code
 +16.41%
4
Baidu
BIDU
+14.36%
5
ASE Technology
ASX
+10.33%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to the latest report by AXIOS, the US expects Iran to respond on several key issues within the next 48 hours. No agreement has bee Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -